Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
543.7 USD | -0.09% | -1.93% | -7.03% |
Strengths
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company benefits from high valuations in earnings multiples.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-7.03% | 8.2B | C+ | ||
+24.66% | 88.38B | C+ | ||
-21.76% | 77.56B | B- | ||
+7.32% | 28.74B | C+ | ||
+7.41% | 18.45B | A- | ||
-13.50% | 16.57B | B | ||
+77.51% | 13.65B | C- | ||
+76.96% | 13.06B | C+ | ||
+4.32% | 12.61B | A- | ||
+36.67% | 12.56B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CHE Stock
- Ratings Chemed Corporation